EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
19 hedge funds and large institutions have $89.7M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
48% less capital invested
Capital invested by funds: $174M → $89.7M (-$84.5M)
Holders
19
Holding in Top 10
4
Calls
$401K
Puts
–
Top Buyers
| 1 | +$2.74M | |
| 2 | +$1.67M | |
| 3 | +$68K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.51K |
Top Sellers
| 1 | -$117K | |
| 2 | -$21.8K | |
| 3 | -$15K | |
| 4 |
JP Morgan Chase
New York
|
-$6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$636 |